BALL KRISTINE M 4
4 · Menlo Therapeutics Inc. · Filed Dec 12, 2018
Insider Transaction Report
Form 4
BALL KRISTINE M
SVP, Corporate Strategy & CFO
Transactions
- Award
Stock Option
2018-12-10+96,000→ 96,000 totalExercise: $5.51Exp: 2028-12-10→ Common Stock (96,000 underlying)
Footnotes (1)
- [F1]The shares subject to the option will vest over a period of four years, with 1/48th of the shares subject to the option vesting monthly.